M. Moossdorff

Clinical tumor stage is the most important predictor of pathological complete response rate after neoadjuvant chemotherapy in breast cancer patients

B. Goorts, Thiemo J. A. van Nijnatten, Linda de Munck et al. · Breast Cancer Research and Treatment · 2017 · 129 citations · Full text

Maastricht Delphi Consensus on Event Definitions for Classification of Recurrence in Breast Cancer Research

M. Moossdorff, Lori M. van Roozendaal, Luc J. A. Strobbe et al. · JNCI Journal of the National Cancer Institute · 2014 · 113 citations · Full text

Prognosis of residual axillary disease after neoadjuvant chemotherapy in clinically node-positive breast cancer patients: isolated tumor cells and micrometastases carry a better prognosis than macrometastases

Thiemo J. A. van Nijnatten, Janine M. Simons, M. Moossdorff et al. · Breast Cancer Research and Treatment · 2017 · 63 citations · Full text

A Model to Predict Pathologic Complete Response of Axillary Lymph Nodes to Neoadjuvant Chemo(Immuno)Therapy in Patients With Clinically Node-Positive Breast Cancer

Robert‐Jan Schipper, M. Moossdorff, Patty J. Nelemans et al. · Clinical Breast Cancer · 2014 · 52 citations

Breast Oncology, Medicine, Immunology +7

International consensus statement regarding the use of animal models for research on anastomoses in the lower gastrointestinal tract

Joanna W. A. M. Bosmans, M. Moossdorff, Mahdi Al‐Taher et al. · International Journal of Colorectal Disease · 2016 · 43 citations · Full text

Animal Physiology, International Consensus Statement, Lower Gastrointestinal Tract +8